Multibagger pharma products stock at Rs 81 - gains over 4 per cent today; Investors to receive 3 free shares for every 1 share held by them: Record Date - July 06, 2024

The stock gave multibagger returns of 1,540 per cent in 2 years, 2,225 per cent in 3 years and a whopping 12,150 per cent in 5 years.

Today, shares of Remedium Lifecare Ltd gained over 4 per cent to an intraday high of Rs 81 with a spurt in volume by 1.01 times from its previous closing of Rs 77.30 per share. The stock’s 52-week high is Rs 179.66 and its 52-week low is Rs 68.73.

The Board has considered approved and recommended a bonus issue of shares in the ratio 3:1 i.e., 3 equity shares of Re 1 each fully paid up for every 1 equity share of Re 1 each fully paid up held as on the Record date decided for this purpose. The company fixed the record date as Saturday, July 06, 2024.

Earlier, the company's shares underwent several changes: a stock split on September 1, 2023, reducing the face value from Rs 10 to Rs 5, another stock split on February 23, 2024, bringing the face value down to Rs 1 and a bonus share issuance on July 28, 2023, in a 9:5 ratio.

Remedium Lifecare Ltd, founded in 1988, is a pharmaceutical company that acts as a middleman for other drug manufacturers. They buy and sell active pharmaceutical ingredients (APIs), which are the core chemicals used in medications, and intermediate chemicals needed to produce those APIs. Remedium deals with both innovative and generic drug companies, supplying them with a variety of products including cholesterol reducers, antidepressants, asthma medications, and allergy medicine ingredients. They source and sell these materials from around the world.

Also Read: Turnaround net profit of Rs 1.74 crore after 5 years: Penny stock at Rs 1.55 gains 16.5 per cent today with heavy volume; Spurt in volume by more than 8 times

Remedium Lifecare Ltd has a market cap of Rs 796 crore with a 3-year stock price CAGR of 182 per cent. The company reported a total income of Rs 1,411.40 crore in Q4FY24 compared to a total income of Rs 75.58 crore in Q4FY23, an increase of 1,768 per cent. The company reported a net loss of Rs 53.72 crore in Q4FY24 compared to a net loss of Rs 4.78 crore in Q4FY23. In its annual results, the company reported total income increased by 698 per cent to Rs 4,062.80 crore and net profit increased by 504 per cent to Rs 32.72 crore in FY24 compared to FY23.

According to the shareholding pattern, the promoters of the company own only a 1.11 per cent stake in the company. In FY24, FIIs took a fresh entry and bought a 0.04 per cent stake in the company and the maximum stake is owned by the public shareholders i.e. 98.85 per cent stake. The shares of the company have a PE of 15x, an ROE of 71 per cent and an ROCE of 103 per cent. The stock gave multibagger returns of 1,540 per cent in 2 years, 2,225 per cent in 3 years and a whopping 12,150 per cent in 5 years.

Disclaimer: The article is for informational purposes only and not investment advice.